Cigna lifts annual profit view on lower medical costs, pharmacy benefit strength
By Bhanvi Satija (Reuters) -Cigna Group raised its annual profit forecast on Thursday, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The health insurer's second forecast raise this year is in sharp co...
7h ago
IQVIA trims full-year revenue forecast on stronger dollar
(Reuters) - Contract research firm IQVIA Holdings lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched metric, sending shares down nearly 4%. The company expects 2024...
7h ago
Digital health startup Transcarent valued at $2.2 billion after latest funding round
(Reuters) - Digital health startup Transcarent notched a valuation of $2.2 billion after its latest fund raise, led by General Catalyst and 7wireVentures, amid signs of a rebound in the funding market. The company said on Thursday it had raised $12...
8h ago
Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
LONDON (Reuters) - Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in th...
10h ago
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
(Reuters) - Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer. Drug distributors, including rival Cencora, ha...
10h ago
Baxter raises annual profit forecast on strong demand for medical devices
(Reuters) - Medical device maker Baxter International raised its annual profit forecast and beat quarterly estimates on Thursday, banking on strong demand for its infusion pumps and dialysis products. Investor expectations around the performance of...
10h ago
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
(Reuters) - Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer's results extend a strong ...
11h ago
Zoetis beats profit estimates on strong demand for pet products
(Reuters) - Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets. Zoetis deals with vaccines, medicines and diagnostic solutions for ...
11h ago
Teleflex beats quarterly profit estimates on healthy demand for medical devices
(Reuters) - Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices. The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted profit forecast to $13...
12h ago
Novartis to buy radiology specialist Mariana Oncology for $1 billion
(Reuters) - Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1 billion, the Swiss drug manufacturer said on Thursday. The deal also includes $750 million of potential further payments upon achieving ...
12h ago
Becton Dickinson lifts profit view on strong surgical equipment demand
(Reuters) - Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes. Medical technology firms like Becton, Boston Scientifi...
12h ago
Moderna quarterly sales beat expectations but plummet from previous year
By Patrick Wingrove (Reuters) - Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was higher. Sales of Moderna's COVID-19 shot Spi...
13h ago
Regeneron misses profit estimates on weaker Eylea and Dupixent sales
(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for first-quarter profit on Thursday due to softer sales of its blockbuster eye drug Eylea and its eczema treatment, Dupixent. Excluding items, the company reported a ...
13h ago
Cigna sees strong annual profit on lower costs, pharmacy benefit strength
(Reuters) - Health insurer Cigna Group raised its annual profit forecast on Thursday, as lower-than-expected medical costs and strength in its pharmacy benefit management unit helped it beat first-quarter earnings estimates. The company now expects...
13h ago
India widens spices crackdown with nationwide checks on all manufacturers
By Rishika Sadam HYDERABAD (Reuters) - India's food safety regulator said on Thursday it had ordered nationwide testing and inspections at all companies making spice mixes, widening a crackdown on the sector as global regulators investigate contam...
15h ago
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast
LONDON (Reuters) - Novo Nordisk posted on Thursday first-quarter operating profit above analyst forecasts, as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly. (Report...
18h ago
British pharmacies vie for weight-loss patients with drug price cuts
By Ludwig Burger (Reuters) - Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply shortages ease. But growing competition between...
19h ago
Bird flu test shows meat supply is safe, USDA says
(Reuters) - The U.S. Department of Agriculture (USDA) said on Wednesday that all the ground beef samples sent to the National Veterinary Services Laboratories (NVSL) for PCR testing, tested negative for H5N1 virus. "NVSL reported that all samples t...
19h ago
Emergent BioSolutions to lay off about 300 employees
(Reuters) -Emergent BioSolutions said on Wednesday that it would cut about 300 jobs across all areas of the company and shut down several manufacturing facilities as part of a restructuring plan. Shares of the company rose about 40% to $2.7 in extended...
May 01, 2024
US judge blocks some North Carolina restrictions on abortion pill
By Brendan Pierson (Reuters) - A federal judge has struck down parts of a North Carolina law restricting patients' access to the abortion pill mifepristone, which has become the subject of legal battles nationwide. U.S. District Judge Catherine Eag...
May 01, 2024
Bird flu testing shows more dairy products are safe, US FDA says
By Julie Steenhuysen and Tom Polansek NEW YORK (Reuters) -The U.S. Food and Drug Administration said on Wednesday that preliminary results of additional testing of more dairy products has shown that pasteurization inactivates the bird flu virus. The FD...
May 01, 2024
VP Harris visits Florida as abortion ban limits southern women's options
By Nandita Bose WASHINGTON (Reuters) - U.S. Vice President Kamala Harris visits Florida on Wednesday to denounce the state's six-week abortion ban that takes effect on May 1, and will accuse Republican opponent Donald Trump of being responsible for...
May 01, 2024
US bird flu outbreak spreads to chickens, cattle, raises concerns over human infections
(Reuters) - The outbreak of H5N1 bird flu virus has spread to dairy cows for the first time in the United States, raising concerns about it spreading to humans through the nation's milk supply. Since 2022, bird flu in the United States has infected...
May 01, 2024
UnitedHealth CEO testifies on hack before U.S. Senate and House
By Ahmed Aboulenein WASHINGTON (Reuters) -UnitedHealth CEO Andrew Witty began his first of two scheduled testimonies in front of Congressional panels on Wednesday, answering questions from lawmakers about the recent cyberattack at the company's technol...
May 01, 2024
Amgen investors await weight-loss drug data
By Deena Beasley (Reuters) - Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-loss drug candidates when it reports quarterly ...
May 01, 2024